BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12378521)

  • 21. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma.
    Yegappan S; Coupland R; Arber DA; Wang N; Miocinovic R; Tubbs RR; Hsi ED
    Mod Pathol; 2001 Nov; 14(11):1147-56. PubMed ID: 11706077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the stomach and small intestine.
    Kwon MS; Go JH; Choi JS; Lee SS; Ko YH; Rhee JC; Ree HJ
    Am J Surg Pathol; 2003 Jun; 27(6):790-8. PubMed ID: 12766583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype.
    Yoshida S; Nakamura N; Sasaki Y; Yoshida S; Yasuda M; Sagara H; Ohtake T; Takenoshita S; Abe M
    Mod Pathol; 2005 Mar; 18(3):398-405. PubMed ID: 15492762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational analysis of IgVH and BCL-6 genes suggests thymic B-cells origin of mediastinal (thymic) B-cell lymphoma.
    Csernus B; Timár B; Fülöp Z; Bognár A; Szepesi A; László T; Jáksó P; Warnke R; Kopper L; Matolcsy A
    Leuk Lymphoma; 2004 Oct; 45(10):2105-10. PubMed ID: 15370257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
    Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
    Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts.
    Sugita Y; Tokunaga O; Nakashima A; Shigemori M
    Pathol Int; 2004 Sep; 54(9):659-66. PubMed ID: 15363033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases.
    Grønbaek K; Møller PH; Nedergaard T; Thomsen K; Baadsgaard O; Hou-Jensen K; Zeuthen J; Guldberg P; Ralfkiaer E
    Br J Dermatol; 2000 May; 142(5):913-23. PubMed ID: 10809848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.
    Belaud-Rotureau MA; Marietta V; Vergier B; Mainhaguiet G; Turmo M; Idrissi Y; Ferrer J; Beylot-Barry M; Dubus P; Merlio JP
    Virchows Arch; 2008 Jun; 452(6):607-20. PubMed ID: 18311490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis.
    Bodoor K; Matalka I; Hayajneh R; Haddad Y; Gharaibeh W
    Asian Pac J Cancer Prev; 2012; 13(7):3037-46. PubMed ID: 22994707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
    Huebner-Chan D; Fernandes B; Yang G; Lim MS
    Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.
    Grange F; Bekkenk MW; Wechsler J; Meijer CJ; Cerroni L; Bernengo M; Bosq J; Hedelin G; Fink Puches R; van Vloten WA; Joly P; Bagot M; Willemze R
    J Clin Oncol; 2001 Aug; 19(16):3602-10. PubMed ID: 11504742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.
    Carbone A; Gloghini A; Larocca LM; Capello D; Pierconti F; Canzonieri V; Tirelli U; Dalla-Favera R; Gaidano G
    Blood; 2001 Feb; 97(3):744-51. PubMed ID: 11157493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell/histiocyte-rich large B-cell lymphoma displays a heterogeneity similar to diffuse large B-cell lymphoma: a clinicopathologic, immunohistochemical, and molecular study of 30 cases.
    Wang J; Sun NC; Chen YY; Weiss LM
    Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):109-15. PubMed ID: 15894921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.
    Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV
    Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.
    Pileri SA; Gaidano G; Zinzani PL; Falini B; Gaulard P; Zucca E; Pieri F; Berra E; Sabattini E; Ascani S; Piccioli M; Johnson PW; Giardini R; Pescarmona E; Novero D; Piccaluga PP; Marafioti T; Alonso MA; Cavalli F
    Am J Pathol; 2003 Jan; 162(1):243-53. PubMed ID: 12507907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
    Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
    Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil.
    Ree HJ; Ohsima K; Aozasa K; Takeuchi K; Kim CW; Yang WI; Huh JY; Lee SS; Ko YH; Kwon MS; Cho EY; Choi YL; Rhee JC; Kikuchi M; Mori S
    Hum Pathol; 2003 Jun; 34(6):610-6. PubMed ID: 12827616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes.
    Goodlad JR; Krajewski AS; Batstone PJ; McKay P; White JM; Benton EC; Kavanagh GM; Lucraft HH;
    Am J Surg Pathol; 2003 Dec; 27(12):1538-45. PubMed ID: 14657713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas.
    Giménez S; Costa C; Espinet B; Solé F; Pujol RM; Puigdecanet E; García-Moreno P; Sánchez J; Gallardo F; Estrach T; García-Muret P; Romagosa V; Serrano S; Servitje O
    Exp Dermatol; 2005 Dec; 14(12):883-90. PubMed ID: 16274455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.